Literature DB >> 33491095

Porokeratosis Plantaris, Palmaris et Disseminata Caused by Con- genital Pathogenic Variants in the MVD Gene and Loss of Hetero-zygosity in Affected Skin.

Sabine Jägle1, Hazem A Juratli, Geoffroy Hickman, Kira Süssmuth, Maria C Boente, Julia Kopp, Peter Kirchmeier, Andreas Zimmer, Rudolf Happle, Emmanuelle Bourrat, Henning Hamm, Judith Fischer.   

Abstract

Porokeratoses are a heterogeneous group of keratinization disorders. For linear porokeratosis and disseminated superficial actinic porokeratosis, a heterozygous pathogenic germline variant in a mevalonate pathway gene and a postzygotic second hit mutation present in affected skin have been shown to be the patho-genetic mechanism for the development of the lesions. However, the molecular mechanism leading to development of porokeratosis plantaris, palmaris et disseminata is not known. This study analysed a cohort of 4 patients with linear porokeratosis and 3 patients with porokeratosis plantaris, palmaris et disseminata, and performed mutation analyses of DNA extracted from blood samples and skin biopsies. All of the study patients carried the heterozygous germline variant c.70+5G>A in the MVD gene. Loss of heterozygosity due to a second hit mutation was found in affected skin of 3 patients with linear porokeratosis and 2 patients with porokeratosis plantaris, palmaris et disseminata. These results suggest that porokeratosis plantaris, palmaris et disseminata shares the same pathogenetic mechanism as other porokeratosis subtypes and belongs to the phenotypic spectrum of MVD-associated porokeratosis.

Entities:  

Keywords:  linear porokeratosis; loss of heterozygosity; mosaicism; palmaris et disseminata; porokeratosis plantaris; second hit; mevalonate diphosphate decarboxylase gene

Mesh:

Year:  2021        PMID: 33491095      PMCID: PMC9366687          DOI: 10.2340/00015555-3753

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  18 in total

1.  Somatic recombination may explain linear porokeratosis associated with disseminated superficial actinic porokeratosis.

Authors:  R Happle
Journal:  Am J Med Genet       Date:  1991-05-01

2.  Keratotic plaques on the left trunk area and all extremities: porokeratosis.

Authors:  Matthias Goebeler; Eva-Bettina Bröcker; Henning Hamm
Journal:  Arch Dermatol       Date:  2006-08

3.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

4.  Porokeratosis palmaris, plantaris et disseminata vs. porokeratosis of Mibelli.

Authors:  R Happle
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

5.  Unusual presentation of porokeratosis palmaris, plantaris et disseminata.

Authors:  R A Neumann; R M Knobler; W Gebhart
Journal:  J Am Acad Dermatol       Date:  1989-11       Impact factor: 11.527

6.  Identification of a locus for porokeratosis palmaris et plantaris disseminata to a 6.9-cM region at chromosome 12q24.1-24.2.

Authors:  S C Wei; S Yang; M Li; Y X Song; X Q Zhang; L Bu; G Y Zheng; X Y Kong; X J Zhang
Journal:  Br J Dermatol       Date:  2003-08       Impact factor: 9.302

7.  Second-Hit Somatic Mutations in Mevalonate Pathway Genes Underlie Porokeratosis.

Authors:  Lihi Atzmony; Keith A Choate
Journal:  J Invest Dermatol       Date:  2019-12       Impact factor: 8.551

8.  Porokeratosis plantaris, palmaris, et disseminata. A third type of porokeratosis.

Authors:  S B Guss; R A Osbourn; M A Lutzner
Journal:  Arch Dermatol       Date:  1971-10

9.  Porokeratosis plantaris, palmaris, et disseminata.

Authors:  M Marschalkó; B Somlai
Journal:  Arch Dermatol       Date:  1986-08

10.  Genomic variations of the mevalonate pathway in porokeratosis.

Authors:  Zhenghua Zhang; Caihua Li; Fei Wu; Ruixiao Ma; Jing Luan; Feng Yang; Weida Liu; Li Wang; Shoumin Zhang; Yan Liu; Jun Gu; Wenlian Hua; Min Fan; Hua Peng; Xuemei Meng; Ningjing Song; Xinling Bi; Chaoying Gu; Zhen Zhang; Qiong Huang; Lianjun Chen; Leihong Xiang; Jinhua Xu; Zhizhong Zheng; Zhengwen Jiang
Journal:  Elife       Date:  2015-07-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.